Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma
{{output}}
Background: Measurable residual disease (MRD) is a major prognostic factor in newly diagnosed multiple myeloma. An assessment of an MRD-guided consolidation strategy in patients who are eligible for autologous stem-cell transplan... ...
